Comparison of the Safety and Efficacy of Ophtesis Bio 3% With a Similar 3% Sodium Hyaluronate OVD

Exclusion Criteria

• •Pupil abnormalities (non-reactive, fixed pupils, or abnormally shaped pupils)
• •Recent ocular trauma or ocular surgery that is not resolved/stable or may affect visual outcomes or increase risk to the subject
• •Use of systemic or ocular medications that may affect IOP
• •Known steroid responder
• •Ocular hypertension of ≥ 20 mmHg, medically-controlled ocular hypertension (regardless of IOP value), or glaucomatous changes in the optic nerve
• •Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes
• •Concurrent participation or participation within 45 days prior to preoperative visit in any other clinical trial